Dreyling, M. Santoro, A. Mollica, L. Leppä, S. Follows, G. Lenz, G. Kim, W.S. Nagler, A. Dimou, M. Demeter, J. Özcan, M. Kosinova, M. Bouabdallah, K. Morschhauser, F. Stevens, D.A. Trevarthen, D. Munoz, J. Rodrigues, L. Hiemeyer, F. Miriyala, A. Garcia-Vargas, J. Childs, B.H. Zinzani, P.L., Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study, American Journal of Hematology, (95), 362-371, 2020, John Wiley and Sons Inc, 0361-8609, 1096-8652